|0.128|| +0.003 / +2.42%|
GenSpera, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. It focuses on the discovery and development of prodrug cancer therapeutics for the treatment of cancerous tumors, including prostate, brain and other cancers. Its technology platform combines, plant-derived cytotoxin with a prodrug delivery system that targets the release of the drug only within the tumor. The company was founded by Craig A. Dionne, John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in San Antonio, TX.
|Russell B. Richerson||CEO, COO, Secretary & Principal Accounting Officer|